These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3652057)

  • 1. Limited sampling model for vinblastine pharmacokinetics.
    Ratain MJ; Vogelzang NJ
    Cancer Treat Rep; 1987 Oct; 71(10):935-9. PubMed ID: 3652057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited sampling model for area under the concentration time curve of total topotecan.
    Minami H; Beijnen JH; Verweij J; Ratain MJ
    Clin Cancer Res; 1996 Jan; 2(1):43-6. PubMed ID: 9816088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A limited sampling strategy for cyclophosphamide pharmacokinetics.
    Egorin MJ; Forrest A; Belani CP; Ratain MJ; Abrams JS; Van Echo DA
    Cancer Res; 1989 Jun; 49(11):3129-33. PubMed ID: 2720671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited sampling models for amonafide (NSC 308847) pharmacokinetics.
    Ratain MJ; Staubus AE; Schilsky RL; Malspeis L
    Cancer Res; 1988 Jul; 48(14):4127-30. PubMed ID: 3383202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.
    Langers P; Cremers SC; den Hartigh J; Rijnbeek EM; Ringers J; Lamers CB; van Hoek B
    Aliment Pharmacol Ther; 2005 Mar; 21(5):549-57. PubMed ID: 15740538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.
    Figurski MJ; Nawrocki A; Pescovitz MD; Bouw R; Shaw LM
    Ther Drug Monit; 2008 Aug; 30(4):445-55. PubMed ID: 18641543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Bayesian approach and a limited sampling model for the estimation of AUC and Cmax: a computer simulation analysis.
    Mahmood I; Miller R
    Int J Clin Pharmacol Ther; 1999 Sep; 37(9):439-45. PubMed ID: 10507242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetic and limited sampling models for carboplatin administered in high-dose combination regimens with peripheral blood stem cell support.
    Shen M; Schilder RJ; Obasaju C; Gallo JM
    Cancer Chemother Pharmacol; 2002 Sep; 50(3):243-50. PubMed ID: 12203107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
    Sibbald C; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL
    Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simultaneous oral/intravenous population pharmacokinetic model for vinorelbine.
    Variol P; Nguyen L; Tranchand B; Puozzo C
    Eur J Clin Pharmacol; 2002 Oct; 58(7):467-76. PubMed ID: 12389069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexible limited sampling model for monitoring tacrolimus in stable patients having undergone liver transplantation with samples 4 to 6 hours after dosing is superior to trough concentration.
    Langers P; Press RR; den Hartigh J; Cremers SC; Baranski AG; Lamers CB; Hommes DW; van Hoek B
    Ther Drug Monit; 2008 Aug; 30(4):456-61. PubMed ID: 18641539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited sampling model for the analysis of 5-fluorouracil pharmacokinetics in adjuvant chemotherapy for colorectal cancer.
    Di Paolo A; Danesi R; Vannozzi F; Falcone A; Mini E; Cionini L; Ibrahim T; Amadori D; Del Tacca M
    Clin Pharmacol Ther; 2002 Dec; 72(6):627-37. PubMed ID: 12496744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etoposide pharmacokinetics in children: the development and prospective validation of a dosing equation.
    Lowis SP; Pearson AD; Newell DR; Cole M
    Cancer Res; 1993 Oct; 53(20):4881-9. PubMed ID: 8402676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A limited sampling approach in bioequivalence studies: application to long half-life drugs and replicate design studies.
    Mahmood I; Mahayni H
    Int J Clin Pharmacol Ther; 1999 Jun; 37(6):275-81. PubMed ID: 10395118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited sampling models for HA-1A IgM monoclonal antibody.
    Hardin JM; Khazaeli MB; Allen IE; Dating C; LoBuglio AF
    Hum Antibodies Hybridomas; 1990; 1(2):115-9. PubMed ID: 2103353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited-sampling models for estimation of the carboplatin area under the curve.
    Miyazaki M; Fujiwara Y; Takahashi T; Isobe T; Ohune T; Tsuya T; Yamakido M
    Anticancer Res; 1997; 17(6D):4571-5. PubMed ID: 9494570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus in diabetic kidney transplant recipients: pharmacokinetics and application of a limited sampling strategy.
    Mendonza AE; Zahir H; Gohh RY; Akhlaghi F
    Ther Drug Monit; 2007 Aug; 29(4):391-8. PubMed ID: 17667791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian estimate of vinorelbine pharmacokinetic parameters in elderly patients with advanced metastatic cancer.
    Gauvin A; Pinguet F; Culine S; Astre C; Gomeni R; Bressolle F
    Clin Cancer Res; 2000 Jul; 6(7):2690-5. PubMed ID: 10914711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of sample pooling methods for determining AUC, AUMC and mean residence times in pharmacokinetic studies.
    Cheung BW; Cartier LL; Russlie HQ; Sawchuk RJ
    Fundam Clin Pharmacol; 2005 Jun; 19(3):347-54. PubMed ID: 15910659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.